Tanke Biosciences Corporation
Tanke Biosciences Corporation, through its subsidiary, Best Energy Monitoring LLC, engages in the energy monitoring business. The company monitors and analyses accurate, itemized, and real-time energy data. Its assets are utilized in the monitoring of energy consumption using internet of things (IoT), big data, and artificial intelligence for commercial buildings, such as food retail, quick servi… Read more
Tanke Biosciences Corporation (TNBI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.003x
Based on the latest financial reports, Tanke Biosciences Corporation (TNBI) has a cash flow conversion efficiency ratio of 0.003x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-869.00) by net assets ($-289.07K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Tanke Biosciences Corporation - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how Tanke Biosciences Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Tanke Biosciences Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tanke Biosciences Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Allied Resources Inc
PINK:ALOD
|
-0.016x |
|
Hiru Corporation
PINK:HIRU
|
-0.018x |
|
BERKELEY GRP - Dusseldorf Stock Exchang
DU:42BA
|
N/A |
|
Intergama
TA:INTR
|
0.054x |
|
CENTRAL SEC. DL 1
F:9G6
|
N/A |
|
OMEGA HLTH INV REIT (WX4.SG)
STU:WX4
|
0.042x |
|
OneApex Limited
F:CWF
|
0.469x |
|
Canoo Holdings Ltd
NASDAQ:GOEVW
|
-0.119x |
Annual Cash Flow Conversion Efficiency for Tanke Biosciences Corporation (2008–2024)
The table below shows the annual cash flow conversion efficiency of Tanke Biosciences Corporation from 2008 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-183.34K | $-34.90K | 0.190x | -75.61% |
| 2023-12-31 | $-95.66K | $-74.66K | 0.781x | +16.25% |
| 2022-12-31 | $-88.13K | $-59.18K | 0.671x | +1040.96% |
| 2021-12-31 | $-59.98K | $-3.53K | 0.059x | +179.14% |
| 2012-12-31 | $15.92 Million | $-1.18 Million | -0.074x | -133.26% |
| 2011-12-31 | $15.85 Million | $3.54 Million | 0.224x | +21622.06% |
| 2010-12-31 | $13.21 Million | $-13.72K | -0.001x | +26.26% |
| 2009-12-31 | $9.52 Million | $-13.41K | -0.001x | -100.18% |
| 2008-12-31 | $-16.56K | $-13.27K | 0.801x | -- |